Psilocybin

PS2025 Psilocybin

The Impact of Psilocybin Use on Parenting: A Maternal Perspective

Amanda Elmore

PS2025 Psilocybin

psilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity

Jamila Hokanson, Sara Reed

PS2025 Psilocybin

Frontiers in Psilocybin Research for OCD: Neural Mechanisms, Treatment Response, and Clinical Implications

Jamila Hokanson, Benjamin Kelmendi, Terence Ching, Ph.D.

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy

Psilocybin-assisted psychotherapy for Generalized Anxiety Disorder: safety and efficacy in a world-first randomized controlled trial

Jamila Hokanson, Paul Liknaitzky

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy

Psilocybin-Therapy for Anorexia Nervosa: Safety, Clinical Outcomes, and Moderators of Response

Jamila Hokanson, Hannah Douglass

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy

A Phase 1/2 study of group retreat psilocybin therapy for metastatic cancer identifies a safe ratio of facilitators to participants

Anthony L Back

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy Veterans

Safety and efficacy of psilocybin-assisted psychotherapy for US military Veterans with PTSD

Stacey Armstrong

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy

Psilocybin-assisted therapy + Mindfulness Based Stress Reduction (MBSR) for front-line healthcare provider COVID-19 related depression and burnout

Anthony L Back, Benjamin Lewis

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy

Psilocybin-assisted Therapy To Enhance Physician Well-being And Reduce Burnout

Anthony L Back, Kush Bhatt

PS2025 Psilocybin Psilocybin-assisted therapy Psychedelic Assisted Therapy

Exploring New Frontiers: Psilocybin Therapy for mood dysfunction in Parkinson’s Disease

Franklin King, Ellen Bradley